# Selection of Chemical Modifications in the siRNA Seed Region That Repress Off-Target Effect **siRNA 种子区化学修饰对脱靶效应的抑制作用** 

Yoshiaki Kobayash, Kengo Miyamoto, Misako Aid and Kumiko Ui-Tei

## Abstract 摘要

RNA interference mediated by small interfering RNA (siRNA) has been widely used as a procedure to knock down the expression of an intended target gene with perfect sequence complementarity. However, siRNA often exhibits off-target effects on genes with partial sequence complementarities. Such off-target effect is an undesirable adverse effect for knocking down a target gene specifically. Here we describe the powerful strategy to avoid off-target effects without affecting the RNAi activity by the introduction of DNA or 2′-*O*-methyl modifications in the siRNA seed region. These two types of chemical modifications repress off-target effects through different molecular mechanisms.

<span style=color:blue>RNA干扰 (RNAi) 介导的小干扰 RNA (siRNA) 已被广泛用于特异性敲减目标基因表达。然而，siRNA 经常对具有部分序列互补性的非靶基因产生脱靶效应，这会影响实验结果的准确性。本文介绍了通过在 siRNA 种子区引入 DNA 或 2'-*O*-甲基修饰来抑制脱靶效应的策略。这两种修饰通过不同的分子机制提高 siRNA 的特异性。</span>

## 1 Introduction 简介

RNA interference (RNAi) is induced by small interfering RNA (siRNA), a duplex composed of the guide and passenger strands of 21-nucleotide (nt)-long RNAs with 2-nt 3′ overhangs. The siRNA is loaded onto Argonaute (AGO) protein , which is a core component of the RNA-induced silencing complex (RISC) . Subsequently, one of the two strands (passenger strand) is ejected and the other strand (guide strand) remains loading on AGO. Then, the guide strand base pairs with its target mRNA with perfect sequence complementarity, leading to repression of gene expression through the cleavage by AGO (Fig. 1). Synthetic siRNAs have become a powerful tool not only for studying gene function but also for applying therapeutics. Because the first siRNA drug was approved by FDA and EMA in 2018, the developmental research for therapeutic applications expected to become popular.

<span style=color:blue>RNA干扰 (RNAi) 由小干扰 RNA (siRNA) 介导，siRNA 是一种双链 RNA 分子，由两条 21 个核苷酸长度组成，其中包含2个核苷酸的3'突出端。siRNA 会被加载到 Argonaut (AGO) 蛋白上，AGO 蛋白是 RNA 诱导沉默复合物 (RISC) 的核心组成部分。加载后，siRNA 的两条链中会有一条 (过客链) 被去除，剩下的一条链 (引导链) 继续结合在 AGO 蛋白上。然后，引导链会与靶 mRNA 序列完全匹配并结合，通过 AGO 蛋白的切割作用抑制靶基因的表达 (见图 1)。合成的 siRNA 不仅是研究基因功能的利器，还被用于治疗领域。由于首个 siRNA 药物在 2018 年获得 FDA 和 EMA 的批准，siRNA 在治疗领域的开发研究正日益受到关注。</span>

![485053_1_En_2_Fig1_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_2_Fig1_HTML.png)

<span style=font-family:楷体>**Fig. 1** Schematic presentation of the mechanisms of siRNA-mediated RNAi and sequence-dependent off-target effects. SiRNA, a duplex composed of the guide and passenger strands, is loaded onto AGO protein. Passenger strand is ejected and guide strand remains loading on AGO. The mRNA with exact complementary sequence with siRNA guide strand is repressed by RNAi through its cleavage by AGO protein. On the other hand, the sequence-dependent off-target effect is induced for the unintended mRNAs with sequence complementarities with siRNA seed region (2–8 nucleotides from the 5′ end of the guide strand) in their 3′UTRs through translational repression.<span style=color:blue>siRNA介导RNAi及序列依赖性脱靶效应示意图。siRNA 是由引导链和乘客链组成的双链分子，加载到 AGO 蛋白上。乘客链被去除，引导链则保持在 AGO 蛋白上。与 siRNA 引导链序列完全互补的 mRNA 会通过 AGO 蛋白的切割而被 RNAi 抑制表达。另一方面，对于具有序列互补性的非靶 mRNA，siRNA 引导链的种子区 (引导链 5' 端的 2-8 个核苷酸) 会与其 3' 非翻译区 (3'UTR) 结合，从而导致序列依赖性脱靶效应，引起翻译抑制。</span></span>

RNAi efficiencies of siRNAs are widely different depending on their sequences, and only a limited fraction of siRNAs, which satisfy the functional siRNA sequence rules, is effective in mammalian cells. Meanwhile, the siRNA often exhibits off-target effects when the siRNA seed region (2–8 nts from the 5′ end of the guide strand) base pairs with the unintended genes (Fig. 1). The off-target effect is considered to be induced by the similar molecular mechanism with miRNA-mediated RNA silencing, which differs from the mechanism of RNAi. Furthermore, the degree of off-target effect is correlated positively with the thermodynamic stability in base-pairing between the seed region of the siRNA guide strand and the unintended mRNA. Therefore, siRNA with low seed-target stability may be a promising tool for target-specific RNAi with little off-target effect. However, the number of the functional siRNA sequences with lower seed-target stability is substantially small.

<span style=color:blue>siRNA 的 RNAi 效率取决于其序列，只有符合功能性 siRNA 序列规则的少部分 siRNA 才可以在哺乳动物细胞内发挥有效作用。然而，当 siRNA 的种子区 (位于引导链 5' 端的 2-8 个核苷酸) 与非靶基因序列碱基配对时，通常会产生脱靶效应 (见图 1)。siRNA 引起的脱靶效应被认为与 microRNA 介导的 RNA 沉默具有相似的分子机制，这种机制不同于 RNAi 机制。此外，脱靶效应的严重程度与 siRNA 引导链种子区和非靶 mRNA 之间碱基配对的热力学稳定性呈正相关。因此，种子区-靶标稳定性较低 (结合力较弱) 的 siRNA 可能成为具有高特异性和低脱靶效应的 RNAi 工具。然而，功能序列库中这种低稳定性 siRNA 的数量非常少。</span>

Thus, we have established the methods to overcome such sequence-dependent limitations using two types of chemical modifications (Fig. 2): One type of chemical modification is DNA and the other is 2′-*O*-methyl (2′-OMe). The results of reporter assay (Fig. 3), structural simulation (Fig. 4), and microarray (Fig. 5) reveal that the seed-dependent off-target effect is able to be reduced by the introduction of DNA and 2′-OMe modifications in the siRNA seed region without reducing RNAi activity through different molecular mechanisms: DNA modification in the siRNA seed region decreased the thermodynamic stability in the seed-target base-pairing stability, and 2′-OMe modification induced steric hindrance in the duplex formation on the AGO protein. These chemical modifications may be useful tools for potential therapeutic applications.

<span style=color:blue>为了克服 siRNA 序列依赖性的限制，我们采用了两种类型的化学修饰方法 (见图 2): 一种是 DNA 修饰，另一种是 2'-O-甲基 (2'-OMe) 修饰。报告基因检测 (见图 3)、结构模拟 (见图 4) 和微阵列分析 (见图 5) 的结果表明，在 siRNA 种子区引入 DNA 和 2'-OMe 修饰能够通过不同的分子机制降低种子依赖性脱靶效应，同时保持 RNAi 的活性。siRNA 种子区的 DNA 修饰降低了种子区与靶标 mRNA 的碱基配对热力学稳定性；而 2'-OMe 修饰则会在 AGO 蛋白上结合的双链 siRNA 中引入空间位阻效应。这些化学修饰方法有望成为未来 siRNA 治疗应用的利器。</span>

![485053_1_En_2_Fig2_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_2_Fig2_HTML.png)

<span style=font-family:楷体>**Fig. 2** Flow for selecting functional siRNAs with reduced sequence-dependent off-target effect by two types of chemical modifications. (**a**) From all of human mRNA sequences, 56,375,087 of 23-mer sequences are selectable. This number of siRNAs is set as 100%. (**b**) Functional siRNA sequences can be selected by using the four rules described in **Note** **1**. (**c**) The siRNAs with sequences containing low seed–target *T*m values (*see* **Note** **2**) for both strands are selected for reduction of off-target effects. (**d**) Using DNA or 2′-OMe modification in the siRNA seed region makes it possible to overcome the sequence limitations of siRNA for reducing seed-dependent off-target effects through different molecular mechanisms: reduction of base-pairing stability by DNA modification, and steric hindrance by 2′-OMe modification.<span style=color:blue>两种化学修饰方法降低 siRNA 序列依赖性脱靶效应的功能 siRNA 选择流程。从所有的人类 mRNA 序列中，可以选择 56,375,087 个 23 核苷酸序列。该 siRNA 数量设置为 100%。 **b）** 可以使用注釋 1 中描述的四条规则来选择功能性 siRNA 序列。 **c）** 选择双链序列中种子区与靶标结合稳定性 (Tm 值，见注釋 2) 较低的 siRNA，以减少脱靶效应。 **d）** 在 siRNA 种子区引入 DNA 或 2'-OMe 修饰，可以通过不同的分子机制克服 siRNA 序列限制以降低种子依赖性脱靶效应：DNA 修饰降低碱基配对稳定性，2'-OMe 修饰引入空间位阻。</font></span></span>

![485053_1_En_2_Fig3_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_2_Fig3_HTML.png)

<span style=font-family:楷体>**Fig. 3** Measurement of RNAi and off-target activities by dual luciferase reporter assays . (Top) Structures of the constructs for luciferase reporter assays. psiCHECK-gCM_VIM270 contains a CM sequence of the siRNA guide strand in the downstream of *Renilla luciferase* CDS (CDS). psiCHECK-gSM_VIM270, psiCHECK-pCM_VIM270, or psiCHEK-pSM_VIM270 contains three tandem repeats of the SM sequences of the guide strand, the CM and SM sequences of the passenger strand, respectively. The reporter assays were performed as follows: HeLa cells were co-transfected with each concentration of unmodified, DNA- or 2′-OMe-modified siVIM-270, with each psiCHECK construct and pGL3 control vector. Cells were harvested 24 h after transfection and relative luciferase activities were measured. (Bottom) Unmodified, DNA- or 2′-OMe-modified siVIM-270 sequences (left). Results of RNAi activities on the guide CM target using psiCHECK-gCM_VIM270, off-target activities on the guide SM target using psiCHECK-gSM_VIM270, RNAi activities on the passenger CM target using psiCHECK-pCM_VIM270 and off-target activities on the passenger SM target using psiCHECK-pSM_VIM270 by the unmodified or modified siVIM-270s. We used siGY441 as siRNA control (siCont). The data were averaged from three independent experiments, and the bar indicates the standard deviation<span style=color:blue>双萤光素酶报告检测 siRNA 的 RNAi 活性和脱靶效应。**上图** 为荧光素酶报告检测的载体结构图。psiCHECK-gCM_VIM270 在 *Renilla 荧光素酶* (Renilla luciferase) 的编码区 (CDS) 下游包含 siRNA 引导链的 CM 序列。psiCHECK-gSM_VIM270、psiCHECK-pCM_VIM270 或 psiCHEK-pSM_VIM270 分别包含三个串联重复的引导链 SM 序列、过客链的 CM 序列和乘客链的 SM 序列。报告检测过程如下：HeLa 细胞与等量未修饰、DNA 修饰或 2'-OMe 修饰的 siVIM-270、每个 psiCHECK 载体和 pGL3 控制载体一起转染。转染 24 小时后收集细胞，并测量相对荧光素酶活性。**下图** 为未修饰、DNA 修饰或 2'-OMe 修饰的 siVIM-270 序列 (左侧)。使用 psiCHECK-gCM_VIM270 检测靶向引导链 CM 序列的 RNAi 活性，使用 psiCHECK-gSM_VIM270 检测靶向引导链 SM 序列的脱靶效应，使用 psiCHECK-pCM_VIM270 检测靶向乘客链 CM 序列的 RNAi 活性，以及使用 psiCHECK-pSM_VIM270 检测未修饰或修饰的 siVIM-270s 靶向乘客链 SM 序列的脱靶效应。我们使用 siGY441 作为 siRNA 对照 (siCont)。数据来自三个独立实验的平均值，柱状图表示标准偏差。</span></span>

![485053_1_En_2_Fig4_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_2_Fig4_HTML.png)

<span style=font-family:楷体>**Fig. 4** Computational prediction of the steric hindrance of 2′-OMe-modified siRNAs loaded on the AGO protein. (**a**) Crystal structure of unmodified 5′-AAA-3′ RNA with K566 and R792 of AGO protein shown by Schirle et al., and the optimized structures of unmodified (**b**) and 2′-OMe-modified (**c**) RNAs with K566 and R792. (**d**) Superposition at C4′-C3′-O3′ of A3 of unmodified RNA with 2′-OMe-modified RNA.<span style=color:blue>计算预测 2'-OMe 修饰 siRNA 加载到 AGO 蛋白上时的空间位阻。**a）** Schirle 等人展示的未修饰 5'-AAA-3' RNA 与 AGO 蛋白 K566 和 R792 的晶体结构，以及未修饰 (b) 和 2'-OMe 修饰 (c) 的 RNA 与 K566 和 R792 的优化结构。 **d）** 未修饰 RNA 的 A3 的 C4'-C3'-O3' 与 2'-OMe 修饰 RNA 的叠加。</span></span>

![485053_1_En_2_Fig5_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_2_Fig5_HTML.png)

<span style=font-family:楷体>**Fig. 5** Microarray analysis of RNAi activities and off-target effects of unmodified, and DNA- and 2′-OMe-modified siRNAs. (**a**) Expression levels of the target vimentin gene in the cells transfected with the unmodified and modified siRNAs relative to that in the mock-transfected cells, respectively. (**b**) MA plots of microarray data of the cells transfected with unmodified, and DNA- and 2′-OMe-modified siRNAs, respectively. The vertical axis indicates the log2 fold change of signal intensity of each gene in each type of siRNA-transfected cells relative to that of mock (*M* value), and the horizontal axis indicates the averaged log10 signal intensity of each gene in mock and siRNA transfection (*A* value). The dark blue dots indicate the transcripts with seed-matched (SM) sequences in the 3′UTRs of the mRNAs, and the light blue dots indicate the other transcripts. (**c**) Cumulative distribution of microarray data of the cells transfected with unmodified, and DNA- and 2′-OMe-modified siRNAs, respectively. The horizontal axis indicates the M value of (**b**), and the vertical axis indicates the cumulative fraction of transcripts. The red line indicates the cumulative curve of SM transcripts, and the black line indicates the cumulative curve of the other non-SM transcripts. (**d**) Mean log2 fold-change of the downregulated SM transcripts compared to those of non-SM transcripts. The horizontal axis indicates the mean fold-change of off-target transcripts in the cells transfected with unmodified, and DNA- and 2′-OMe-modified siRNAs, respectively.<span style=color:blue>未修饰、DNA 修饰和 2'-OMe 修饰 siRNA 的 RNAi 活性和脱靶效应的芯片分析。**a）** 分别转染未修饰和修饰 siRNA 的细胞中，靶向中间filament 蛋白 (vimentin) 基因的表达水平相对于 mock (空载) 转染细胞的表达水平。**b）** 未修饰、DNA 修饰和 2'-OMe 修饰 siRNA 转染细胞的芯片数据 MA 图。纵轴表示每种类型的 siRNA 转染细胞中每个基因信号强度 (强度) 的 log2 fold 变化 (相对于 mock 的 *M 值*)，横轴表示 mock 和 siRNA 转染细胞中每个基因平均的 log10 信号强度 (*A 值*)。深蓝色圆点表示 mRNA 的 3'UTR 中具有种子匹配序列 (SM) 的转录本，浅蓝色圆点表示其他转录本。**c）** 未修饰、DNA 修饰和 2'-OMe 修饰 siRNA 转染细胞的芯片数据累积分布图。横轴表示 (b) 的 M 值，纵轴表示转录本的累积分数。红色曲线表示 SM 转录本的累积曲线，黑色曲线表示其他非 SM 转录本的累积曲线。**d）** 下调调控的 SM 转录本与非 SM 转录本相比的平均 log2 fold 变化。横轴表示未修饰、DNA 修饰和 2'-OMe 修饰 siRNA 转染细胞中脱靶转录本的平均 fold 变化值。</span>

## 2 Materials 材料

### 2.1 Design and Preparation of siRNAs siRNA的设计与制备

1. siDirect2.0 software: http://siDirect2.RNAi.jp

2. Guide strand sequence of siRNA against human vimentin gene <span style=color:blue>针对人波形蛋白基因的siRNA的引导链序列</span> (siVIM-270): 5′-UUGAACUCGGUGUUGAUGGCG-3′.

3. Passenger strand sequence against human vimentin gene <span style=color:blue>针对人波形蛋白基因的过客链序列</span>(siVIM-270): 5′-CCAUCAACACCGAGUUCAAGA-3′.

   siRNA against green fluorescent protein (siGY441), which does not have perfectly complementary sequences in complete-match (CM) and seed-match (SM) reporter constructs (*see* Subheading 2.2), is used as a negative control.

   <span style=color:blue>针对绿色荧光蛋白 (siGY441) 的 siRNA 用作阴性对照，该蛋白在完全匹配 (CM) 和种子匹配 (SM) 报告构建体中不具有完全互补的序列（*参见*小标题 2.2）。</span>

4. Guide strand of siGY441<span style=color:blue>siGY441的引导链序列</span>: 5′-AUGAUAUAGACGUUGUGGCUG-3′.

5. Passenger strand of siGY441<span style=color:blue>siGY441的过客链序列</span>: 5′-GCCACAACGUCUAUAUCAUGG-3′.

6. Annealing buffer <span style=color:blue>退火缓冲液</span> (2×): 40 mM NaCl, 20 mM Tris–HCl, pH 7.5.

7. 19% Polyacrylamide gel <span style=color:blue>聚丙烯酰胺凝胶</span>.

8. TBE buffer.

### 2.2 Luciferase Reporter Vector and Oligonucleotides with CM and SM Sequences 荧光素酶报告载体和具有 CM 和 SM 序列的寡核苷酸

1. psiCHECK-1 vector <span style=color:blue>载体</span> (Promega). 

2. Oligonucleotides with CM sequences of siVIM-270 guide strand (gCM) with cohesive XhoI/EcoRI ends <span style=color:blue>具有 siVIM-270 引导链 (gCM) 的 CM 序列（具有粘性 XhoI/EcoRI 末端）的寡核苷酸:</span> 5′-tcgaGCGCCATCAACACCGAGTTCAAGAG-3′ and 5′-aattCTCTTGAACTCGGTGTTGATGGCGC-3′.

3. Oligonucleotides with three tandem repeats of SM sequences of siVIM-270 guide strand (gSM) with cohesive XhoI/EcoRI ends <span style=color:blue>具有 siVIM-270 引导链 (gCM) CM 序列的三个串联重复序列和粘性 XhoI/EcoRI 末端的寡核苷酸:</span> 5′-tcgaGAATGATGCACCAGGAGTTCAAGAAATGATGCACCAGGAGTTCAAGAAATGATGCACCAGGAGTTCAAGAG-3′ and 5′-aattCTCTTGAACTCCTGGTGCATCATTTCTTGAACTCCTGGTGCATCATTTCTTGAACTCCTGGTGCATCATTC-3′.

4. Oligonucleotides with three tandem repeats of CM sequences of siVIM-270 passenger strand (pCM) with cohesive XhoI/EcoRI ends <span style=color:blue>具有 siVIM-270 过客链 (pCM) CM 序列的三个串联重复序列和粘性 XhoI/EcoRI 末端的寡核苷酸</span>: 5′-tcgaTCTTGAACTCGGTGTTGATGGCGAATCTTGAACTCGGTGTTGATGGCGAATCTTGAACTCGGTGTTGATGGCGAA-3′ and 5′-aattTTCGCCATCAACACCGAGTTCAAGATTCGCCATCAACACCGAGTTCAAGATTCGCCATCAACACCGAGTTCAAGA-3′.

5. Oligonucleotides with three tandem repeats of CM sequences of siVIM-270 passenger strand (pSM) with cohesive XhoI/EcoRI ends <span style=color:blue>具有 siVIM-270 过客链 (pSM) CM 序列的三个串联重复序列和粘性 XhoI/EcoRI 末端的寡核苷酸:</span> 5′-tcgaAATGATGCACCAGGAGTTGATGGAATGATGCACCAGGAGTTGATGGAATGATGCACCAGGAGTTGATGG-3′ and 5′-aattCCATCAACTCCTGGTGCATCATTCCATCAACTCCTGGTGCATCATTCCATCAACTCCTGGTGCATCATT-3′.

### 2.3 Cell Culture 细胞培养

1. Human HeLa cells or other culture cells <span style=color:blue>人HeLa细胞或其他培养细胞。</span>

2. 24-Well plate (Sumitomo Bakelite) <span style=color:blue>24孔板 (Sumitomo Bakelite)</span>

### 2.4 Transfection and Luciferase Reporter Assay Reagents 转染和荧光素酶报告基因检测试剂

1. pGL3-Control vector (Promega).<span style=color:blue>pGL3-对照载体（Promega）</span>

2. Lipofectamine 2000 reagent (Thermofisher). <span style=color:blue>Lipofectamine 2000试剂(Thermofisher)。</span>

3. Dual-Luciferase Reporter Assay System (Promega).<span style=color:blue>双荧光素酶报告基因检测系统(Promega)。</span>

4. 1× passive lysis buffer (Promega).<span style=color:blue>1×被动裂解缓冲液（Promega）。</span>

### 2.5 Calculation of *T*~m~ *T*~m~（解链温度）计算

The melting temperature (*T*~m~) values are calculated using the following formula using Δ*H* and Δ*S* thermodynamic parameters shown in Xia et al.  and Sugimoto et al..

<span style=color:blue>解链温度（*T*~m~）使用下式计算，热力学参数Δ*H*和 Δ*S*采用夏以及杉本等人文章中的值。</span>

$$ {T}_{\mathrm{m}}=\left\{\left(1000\times \Delta H\right)/\left[A+\Delta S+\ln \left(\mathrm{Ct}/4\right)\right]\right\}-273.15+16.6\mathrm{log}\left[{\mathrm{Na}}^{+}\right]. $$

- Δ*H* (kcal/mol), sum of nearest neighbor enthalpy change<span style=color:blue>最近邻焓变之和。</span>
- *A*, helix initiation constant (−10.8)<span style=color:blue>螺旋起始常数（−10.8）。</span>
- Δ*S*, sum of nearest neighbor entropy change<span style=color:blue>最近邻熵变之和。</span>
- *R*, gas constant (1.987 cal/deg/mol)<span style=color:blue>气体常数 (1.987 cal/deg/mol)。</span>
- Ct, total molecular concentration of strand (100μM)<span style=color:blue>链的总分子浓度（100μM）。</span>
- Fix [Na+] at 100 mM.<span style=color:blue>将 [Na^+^] 固定在 100 mM。</span>

### 2.6 Microarray Analysis 微阵列分析

1. RNeasy kit (Qiagen).

2. NanoDrop 2000 spectrophotometer (Thermo Scientific).

3. Bioanalyzer (Agilent).

4. Agilent one-color spike mix kit (Agilent).

5. Agilent SurePrint G3 human GE microarray (8 × 60 K, ver. 2.0, 3.0) (Agilent).

## 3 Methods 方法

### 3.1 Designing and Preparing siRNAs with DNA or 2′-OMe Modifications in the Seed Region 设计和制备在种子区域具有 DNA 或 2'-OMe 修饰的 siRNA

Highly functional siRNAs for mammalian cells (*see* **Note** **1**) can be designed using the web-based online software, siDirect 2.0. In this section, the procedure for selecting highly functional siRNA for human vimentin is shown as an example.

<span style=color:blue>对于哺乳动物细胞(*见注释1*)，可以使用基于网络的在线软件siDirect 2.0设计高功能的siRNA。本节以选择人维门蛋白高功能siRNA为例展示该过程。</span>

1. Open “http://siDirect2.RNAi.jp/” with any appropriate web browser.  <span style=color:blue>打开网页浏览器，访问 siDirect 2.0 网站：http://siDirect2.RNAi.jp/</span>

2. Input the cDNA sequence of vimentin in a nucleotide sequence box. Or enter the accession number of human vimentin (NM_003380) into the upper blank box.<span style=color:blue>将 vimentin cDNA 序列粘贴到核苷酸序列输入框中。或者，在顶部文本框中输入人类 vimentin 的基因序列编号 (NM_003380)。</span>

3. Click “retrieve sequence” to get the nucleotide sequence from GenBank (https://www.ncbi.nlm.nih.gov/genbank).<span style=color:blue>点击 “retrieve sequence” 按钮，从 GenBank 数据库 (https://www.ncbi.nlm.nih.gov/genbank) 获取核苷酸序列。</span>

4. Click the “Options: [click here]” button to set optional parameters if necessary (*see* **Note** **2**).<span style=color:blue>根据需要，点击“Option:[click here]”按钮，设置可选参数。</span>

5. Click “design siRNA ,” and you can get result.<span style=color:blue>点击 “design siRNA” 按钮，即可获得 siRNA 设计结果。</span>

6. Synthesize siRNAs shown in Fig. 3 with or without DNA and 2′-OMe modifications in the siRNA seed region chemically, respectively (*see* **Note** **3**).<span style=color:blue>参照 Fig. 3 的 siRNA 序列，分别化学合成未修饰的 siRNA 以及 siRNA 种子区引入 DNA 或 2'-OMe 修饰的 siRNA (见注释 3)</span>

7. Mix the solutions containing same amounts of guide and passenger strand RNAs, and add the same volume of 2× annealing buffer, and anneal by incubating the mixture at 95 °C for 3 min, at 37 °C for 30 min, and at 25 °C for 60 min.<span style=color:blue>将等摩尔的引导链和过客链 RNA 溶液混合，加入等体积的 2× 退火缓冲液，混合物按如下程序退火：95 °C 孵育 3 分钟，37 °C 孵育 30 分钟，25 °C 孵育 60 分钟。</span>

8. Annealed products may be checked using 19% polyacrylamide gel electrophoresis in TBE buffer, which can separate 21-nt double-stranded siRNA with 2-nt 3′ overhangs from single-stranded RNA . <span style=color:blue>退火产物可以通过 TBE 缓冲液中的 19% 聚丙烯酰胺凝胶电泳进行检测。该方法可以将具有 2 个核苷酸 3' 末端突出结构的 21 核苷酸双链 siRNA 与单链 RNA 区分开来。</span>

### 3.2 Preparing Luciferase Reporters with CM and SM Sequences 利用 CM 和 SM 序列制备荧光素酶报告基因

1. Both strands of DNA oligonucleotides for gCM and gSM reporters, or pCM and pSM reporters are mixed, respectively, and add the same volume of 2× annealing buffer. They are annealed by incubating at 95 °C for 3 min, at 37 °C for 30 min, and at 25 °C for 60 min.

   <span style=color:blue>将 gCM 和 gSM 报告基因或 pCM 和 pSM 报告基因的 DNA 寡核苷酸双链分别混合，并加入等体积的 2× 退火缓冲液。 按以下步骤进行退火：95 °C 孵育 3 分钟，37 °C 孵育 30 分钟，25 °C 孵育 60 分钟。</span>

2. Insert the annealed oligonucleotides into the XhoI/EcoRI restriction enzyme sites within 3′ UTR region of *Renilla* luciferase gene in psiCHECK-1, and name each plasmid vector, such as psiCHECKgCM_VIM270, psiCHECK-gSM_VIM270, psiCHECK-pCM_VIM270, and psiCHECK-pSM_VIM270, respectively (Fig. 3). RNA silencing activities of the guide strand and passenger strand are measured using psiCHECKgCM_VIM270 and psiCHECK-pCM_VIM270, respectively. The seed-dependent off-target effects of the guide strand and passenger strand are measured using psiCHECK-gSM_VIM270 and psiCHECK-pSM_VIM270, respectively (*see* **Note** **4**).

   <span style=color:blue>将退火后的寡核苷酸插入 psiCHECK-1 中 Renilla 荧光素酶基因的 3'UTR 区 XhoI/EcoRI 限制性酶切位点，并分别命名质粒载体，例如 psiCHECKgCM_VIM270、psiCHECK-gSM_VIM270、psiCHECK-pCM_VIM270 和 psiCHECK-pSM_VIM270 (见图 3)。 分别使用 psiCHECKgCM_VIM270 和 psiCHECK-pCM_VIM270 来测量引导链和乘客链的 RNA 沉默活性。 分别使用 psiCHECK-gSM_VIM270 和 psiCHECK-pSM_VIM270 来测量引导链和乘客链的种子依赖性脱靶效应 (见注释 4)。</span>

### 3.3 RNA Silencing Activity Assay Using the Dual Luciferase Reporter System 利用双荧光素酶报告系统进行RNA沉默活性测定

RNA silencing activity is measured using dual luciferase reporter assay system.

<span style=color:blue>利用双荧光素酶报告测定系统测量RNA沉默活性。</span>

1. Inoculate a human HeLa cell suspension (1.0 × 105 cells/mL) into a well of 24-well culture plate 1 day before transfection.

   <span style=color:blue>在24孔培养板的一个孔中接种人类HeLa细胞悬浮液（1.0 × 10^5^ 细胞/mL），在转染前一天进行接种。</span>

2. Transfect 0.0005, 0.005, 0.05, 0.5, 5 nM of each siRNA (*see* **Note** **5**), 0.1μg of pGL3-Control vector encoding the firefly luciferase gene, and 0.1μg of each psiCHECK-gCM_VIM270, psiCHECK-gSM_VIM270, psiCHECK-pCM_VIM270, and psiCHECK-pSM_VIM270 reporter construct simultaneously into HeLa cells using 2μL of Lipofectamine 2000.

   <span style=color:blue>使用2μL Lipofectamine 2000，将每个siRNA的0.0005、0.005、0.05、0.5、5 nM（*见* **注释5**），0.1μg编码萤火虫荧光素基因的pGL3-Control载体，以及0.1μg每个psiCHECK-gCM_VIM270、psiCHECK-gSM_VIM270、psiCHECK-pCM_VIM270和psiCHECK-pSM_VIM270报告构建同时转染到HeLa细胞中。</span>

3. Lyse the transfected cells with 1× passive lysis buffer 24 h after transfection (*see* **Note** **6**).

   <span style=color:blue>在转染后24小时，用1×被动裂解缓冲液裂解转染的细胞（*见* **注释6**）。</span>

4. Measure luciferase activity using the Dual-Luciferase Reporter Assay System.

   <span style=color:blue>使用双荧光素酶报告试剂盒测量荧光素活性。</span>

5. Calculate the percentage of the *Renilla* luciferase activity normalized by firefly luciferase activity (*Renilla* luciferase activity/firefly luciferase activity × 100) for unmodified siRNA, and siRNA with DNA (*see* **Note** **7**) or 2′-OMe (*see* **Note** **8**) modification in the seed region.

   <span style=color:blue>计算未修饰siRNA，以及在种子区域具有DNA（*见* **注释7**）或2′-OMe（*见* **注释8**）修饰的siRNA的*Renilla*荧光素活性相对于萤火虫荧光素活性的百分比（*Renilla*荧光素活性/萤火虫荧光素活性 × 100）。</span>

### 3.4 Microarray Analysis

1. Inoculate HeLa cells in each 2 wells of 24-well plate at 1 × 10^5^ cells/mL.

   <span style=color:blue>在 24 孔培养板的每个孔中接种 1.0 × 10^5^ 个/mL 的 HeLa 细胞，每个样品重复 2 孔。</span>

2. Transfect 50 nM of each siRNA into HeLa cells using 2μL of Lipofectamine 2000. Prepare mock-transfected cells treated with the transfection reagent in the absence of siRNA as a control.

   <span style=color:blue>使用 2μL 的 Lipofectamine 2000 将 50 nM 的 siRNA 转染到 HeLa 细胞中。 作为对照，制备模拟转染的细胞，即仅用转染试剂处理而不添加 siRNA。</span>

3. At 24 h post-transfection, purify total RNA from the transfected cells using an RNeasy kit.

   <span style=color:blue>转染 24 小时后，使用 RNeasy 试剂盒从转染的细胞中纯化总 RNA。</span>

4. Measure the concentration of purified RNA using a NanoDrop 2000 spectrophotometer and confirm its quality by a Bioanalyzer (*see* **Note** **9**).

   <span style=color:blue>使用NanoDrop 2000分光光度计测量纯化RNA的浓度，并通过Bioanalyzer确认其质量（*见* **注释9**）。</span>

5. Synthesize cDNA from 1μg of each total RNA sample using an Agilent one-color spike mix kit.

   <span style=color:blue>使用Agilent单色探针混合试剂盒从1μg每个总RNA样品合成cDNA。</span>

6. Hybridize the cDNA product to an Agilent SurePrint G3 human GE microarray according to the manufacturer’s protocol.

   <span style=color:blue>根据制造商的方案，将cDNA产物杂交到Agilent SurePrint G3人类GE微阵列上。</span>

7. Calculate the reduction of the expression levels of target vimentin mRNAs in the cells transfected with each siRNA relative to that in the mock-transfected cells, respectively.

   <span style=color:blue>分别计算每个siRNA转染细胞中靶标波形蛋白mRNA表达水平相对于未转染细胞的降低。</span>

8. Generate *M* (log ratio) and *A* (mean average) (*MA*) plot and cumulative distribution using microarray data of each siRNA by package in R-studio software to evaluate the RNA silencing activity (*see* **Note** **10**) and off-target effect (*see* **Note** **11**).

   <span style=color:blue>使用R-studio软件中的包，通过微阵列数据生成*M*（对数比率）和*A*（平均值）（*MA*）图和累积分布，评估RNA沉默活性（*见* **注释10**）和非靶效应（*见* **注释11**）。</span>

## 4 Notes 注释

1. siRNAs satisfied the following four sequence conditions simultaneously are considered to be functional: (a) A/U at the 5′-terminus of the siRNA guide strand, (b) G/C at the 5′-terminus of the siRNA passenger strand, (c) AU richness at the 5′ one-third of the guide strand, (d) absence of a long GC stretch (>9 nt). Bioinformatics analysis revealed that 14.7% of all the 23-mer subsequences in human mRNA satisfy functional siRNA sequence rules  (Fig. 2a, b).

   <span style=color:blue>满足以下四个序列条件的siRNA同时被认为是功能性的：（a）siRNA导引链的5'-末端为A/U，（b）siRNA被动链的5'-末端为G/C，（c）导引链的前1/3位置富含AU，（d）不存在长的GC连续序列（>9 nt）。生物信息学分析显示，人类mRNA中所有23个核苷酸子序列中有14.7%满足功能性siRNA序列规则（见图2a，b）。</span>

2. Using options, other siRNA selection algorithms established by Reynolds et al. or Amarzguioui and Prydz can be selected. Furthermore, the highly effective siRNA with reduced seed-dependent off-target effect is selectable using *T*~m~ value in the seed-target duplex below 21.5 °C. *T*~m~ value is a good benchmark to express the thermodynamic stability of the duplex between siRNA seed region and target mRNA. Calculated *T*~m~ value of siRNA seed-target duplex in protein-free condition discriminates siRNA with almost weak off-target effect from that with strong off-target effect. Specificity of siRNA sequence in human, mouse, or rat can be also checked. Other options which impose the number of contiguous GC or AT nucleotides or GC content are also available. 

   <span style=color:blue>可以使用Reynolds等人或Amarzguioui和Prydz建立的其他siRNA选择算法。此外，可以使用*T* ~m~值在21.5°C以下的siRNA选择高效的siRNA，以减少种子依赖性的非靶效应。*T* ~m~值是表达siRNA种子区域与靶mRNA之间的双链热力学稳定性的良好基准。在无蛋白条件下计算的siRNA种子-靶双链的*T* ~m~值可将几乎没有非靶效应的siRNA与具有强非靶效应的siRNA区分开。还可以检查人类、小鼠或大鼠siRNA序列的特异性。还提供了其他选项，例如连续GC或AT核苷酸的数量或GC含量。</span>

3. DNA is a modified form of RNA with hydrogen at 2′-position of the pentose sugar. The 5′ one-third of siRNA is capable of replacement with DNA without substantial loss of RNAi activity. 2′-OMe is a well-known C2′-modified RNA that is known to increase stability in the serum and thermodynamic stability in base-pairing, and also considered to abrogate immunogenicity. 2′-OMe modification is tolerated at multiple positions in the siRNA guide strand because of its small size, comparable to the 2′-OH of natural RNA. 

   <span style=color:blue>DNA是RNA的一种修改形式，在五碳糖的2'-位置具有氢。siRNA的前1/3位置可用DNA替换而不会显著降低RNAi活性。2'-OMe是一种众所周知的C2'-修饰RNA，它可以增加在血清中的稳定性和碱基对稳定性，还被认为可以减少免疫原性。由于其与天然RNA的2'-OH大小相似，2'-OMe修饰可在siRNA导引链的多个位置耐受。</span>

4. In RNAi, a target mRNA is reduced by cleavage of target mRNA by AGO2. However, miRNA-mediated RNA silencing is induced by translational repression. 

   <span style=color:blue>在RNAi中，通过AGO2的靶mRNA切割来降低目标mRNA。然而，miRNA介导的RNA沉默是通过转译抑制诱导的。</span>

5. It is preferable to perform reporter assays at a series of multiple concentrations of each siRNA to calculate the IC~50~ of its RNA silencing activity quantitatively. 

   <span style=color:blue>最好在每种siRNA的一系列多个浓度下执行报告基因分析，以定量计算其RNA沉默活性的IC~50~。</span>

6. If the cell debris is formed from transfected cells, it is preferable to remove the debris clearly before addition of 1× passive lysis buffer to measure the luciferase activity correctly. 

   <span style=color:blue>如果由转染细胞形成细胞碎片，则最好在添加1×无活性裂解缓冲液之前清除碎片，以正确测量荧光素酶活性。</span>

7. Unmodified siVIM-270 repressed the *Renilla* luciferase activity derived from psiCHECK-gCM for siVIM-270 (psiCHECK-gCM_VIM270) in a dose-dependent manner (Fig. 3). The calculated IC~50~ was 2 pM (Table 1). DNA-modified siVIM-270 repressed the *Renilla* luciferase activity at the almost equivalent level to that of unmodified siVIM-270, particularly at high concentrations (0.5 or 5 nM), and their IC~50~ was 4 pM (Table 1). The off-target effects on the SM target of the guide strand were also measured using psiCHECK-gSM_VIM270 (Fig. 3). Unmodified siVIM-270 showed strong off-target effects (IC~50~ = 10 pM), but DNA-modified siVIM-270 reduced the off-target effects (IC~50~ = 295 pM) (Table 1). This may be because thermodynamic stability in base-pairing of DNA-RNA duplex is weaker than that of RNA duplex. In fact, the calculated *T*m value of the RNA duplex between the seed region of unmodified siVIM-270 and target RNA was 31.4 °C, and that of DNA-RNA heteroduplex between the seed region of DNA-modified siVIM-270 and target RNA was 3.1 °C. Furthermore, it is possible that the passenger strand also induces unintended RNAi and seed sequence-dependent off-target effects. Then dual luciferase reporter assays were also performed using psiCHECK-pCM_VIM270 and psiCHECK-pSM_VIM270, respectively. However, almost no or little inhibitory effects on both CM and SM targets of the passenger strand were observed (Fig. 3). Because we used siRNA satisfying the four functional siRNA sequence conditions, such siRNA is expected to be easily unwound from the 5′ terminus of the guide strand, but not that of the passenger strand. 

   <span style=color:blue>未修改的siVIM-270以剂量依赖的方式抑制了从psiCHECK-gCM_VIM270（siVIM-270的psiCHECK-gCM_VIM270派生的*Renilla*荧光素酶活性）产生的*Renilla*荧光素酶活性（见图3）。 计算得到的IC~50~为2 pM（表1）。 DNA修饰的siVIM-270在高浓度（0.5或5 nM）下抑制了*Renilla*荧光素酶活性，其IC~~50~~几乎与未修改的siVIM-270相当（表1）。 在psiCHECK-gSM_VIM270上也测量了引导链SM目标的非特定效应（见图3）。 未修改的siVIM-270显示出强烈的非特定效应（IC~50~ = 10 pM），但DNA修饰的siVIM-270减少了非特定效应（IC~50~ = 295 pM）（表1）。 这可能是因为DNA-RNA双链的碱基配对的热力学稳定性比RNA双链要弱。 实际上，未修改的siVIM-270种子区域与目标RNA之间的RNA双链的计算*T*m值为31.4°C，而DNA修饰的siVIM-270种子区域与目标RNA之间的DNA-RNA杂交双链的*T*m值为3.1°C。 此外，过客链也可能引发非预期的RNA干扰和种子序列依赖的非特定效应。 然后，还使用psiCHECK-pCM_VIM270和psiCHECK-pSM_VIM270进行了双荧光素酶报告基因测定，分别用于观察过客链的CM和SM目标的抑制效果。 然而，几乎未观察到对过客链的CM和SM目标的抑制作用（见图3）。 因为我们使用了满足四个功能性siRNA序列条件的siRNA，所以预期这种siRNA易于从引导链的5'末端解开，但不易于从过客链解开。</span>

8. The 2′-OMe-modified siVIM-270 repressed the *Renilla* luciferase activity derived from psiCHECK-gCM for siVIM-270 (psiCHECK-gCM_VIM270) at the almost equivalent level to that of unmodified siVIM-270, and its IC50 was 10 pM (Table 1). The off-target effects on the SM target of the guide strand of 2′-OMe-modified siVIM-270 measured using psiCHECK-gSM_VIM270 was significantly reduced, even though this modification is well-known modification to enhance base-pairing stability. It is known that the phosphates of RNA oligonucleotides interact with the amino acid side chains of human AGO protein. Therefore, 2′-OMe-modified single-stranded RNA structure on the AGO protein was examined computationally (Fig. 4). The 2′-OMe modification in the siRNA seed region at position 3 was essentially stable on the AGO protein. However, RNA structure of the nucleotide adjacent to the 2′-OMe-modified nucleotide was changed from that of unmodified RNA (Fig. 4a-d), suggesting that 2′-OMe modification in the siRNA seed region at least at position 3 from 5′ end may disturb base-pairing between siRNA guide strand and its target or off-target mRNAs. But, as shown in Fig. 3, the expression of the CM target was significantly repressed, suggesting that the non-seed region may compensate the incomplete seed-target base pairing for inducing RNAi on the CM target. 

   <span style=color:blue>2′-OMe修饰的siVIM-270在抑制源自psiCHECK-gCM_VIM270的*Renilla*荧光素酶活性方面几乎与未修改的siVIM-270相当，其IC50为10 pM（表1）。 使用psiCHECK-gSM_VIM270测量的2′-OMe修饰的siVIM-270引导链SM目标的非特定效应显着减少，即使这种修饰是已知的增强碱基配对稳定性的修饰。 众所周知，RNA寡核苷酸的磷酸与人类AGO蛋白的氨基酸侧链相互作用。 因此，通过计算分析了AGO蛋白上的2′-OMe修饰的单链RNA结构（见图4）。 在AGO蛋白上，siRNA种子区域中位置3的2′-OMe修饰基本稳定。 但是，与未修饰的RNA相比，2′-OMe修饰的核苷酸相邻核苷酸的RNA结构发生了变化（见图4a-d），表明至少从5'端的位置3处的siRNA种子区域的2′-OMe修饰可能会干扰siRNA引导链与其靶向或非特定mRNA之间的碱基配对。 但是，如图3所示，CM目标的表达显着受到抑制，表明非种子区域可能会补偿不完整的种子-靶标碱基配对以诱导对CM靶标的RNA干扰。</span>

9. Particularly, it is recommended that the value of RNA Integrity Number (RIN), a quantitative measurement of RNA quality, of total RNA sample for microarray application is high. High-quality samples with RIN values higher than 9 are best for microarray application, but the reliable results are also obtained from the sample with the value as low as 7.0. 

   <span style=color:blue>特别建议微阵列应用的总RNA样品的RNA完整性数值（RIN），这是RNA质量的定量测量值，应该很高。RIN值高于9的高质量样品最适合于微阵列应用，但从RIN值低至7.0的样品中也可以获得可靠的结果。</span>

10. Unmodified siVIM-270 repressed the expression level of vimentin mRNA to 11%. DNA- and 2′-OMe-modified siVIM-270 repressed vimentin mRNA expression at almost equivalent level to 13% and 19%, respectively (Fig. 5a). 

    <span style=color:blue>未修饰的siVIM-270将波形蛋白mRNA的表达水平降低到11％。DNA和2'-OMe修饰的siVIM-270将波形蛋白mRNA的表达水平降低到几乎等同于13％和19％的水平（见图5a）。</span>

11. The seed-dependent off-target effect of each siRNA using microarray data can be evaluated by analyzing the expression profiles of genes with seed matched sequences in their 3′UTRs, since siRNA off-target effect is mainly induced by the mechanism similar to miRNA-mediated RNA silencing. Off-target effects on mRNAs having complementary sequences with siRNA seed region in their 3′UTRs were examined. The obvious off-target effects were observed by the introduction of unmodified siVIM-270. However, DNA-modified siVIM-270 showed reduced off-target effects. On the other hand, 2′-OMe-modified siRNA showed little off-target effects (Fig. 5b-d). 

    <span style=color:blue>利用微阵列数据评估每个siRNA的种子依赖性非靶效应可以通过分析其3'UTR中具有种子匹配序列的基因的表达谱来进行，因为siRNA非靶效应主要是通过与miRNA介导的RNA沉默类似的机制诱导的。通过引入未修饰的siVIM-270观察到明显的非靶效应。然而，DNA修饰的siVIM-270显示出减少的非靶效应。另一方面，2'-OMe修饰的siRNA显示出很少的非靶效应（见图5b-d）。</span>

**Table 1** IC~50~s of unmodified, DNA-modified, or 2′-OMe-modified siVIM-270 for RNAi activity or off-target effect measured by reporter assay<span style=color:blue>未修饰、DNA 修饰或 2'-OMe 修饰的 siVIM-270 对于 RNAi 活性或通过报告基因测定测量的脱靶效应的 IC~50~s</span>

| siRNA  | RNAi (pM) | Off-target effect (pM) |
| :----- | :-------- | :--------------------- |
| RNA    | 2         | 10                     |
| DNA    | 4         | 295                    |
| 2′-OMe | 10        | ∞                      |

∞ 表示 IC50 远超过 5000 pM